Novartis Sells Global Rights to Elidel, A Medicine to Treat Atopic Dermatitis - Drugs.com MedNews
Links shared publicly online about this topic.
- 383total visits
Novartis Sells Global Rights to Elidel, A Medicine to Treat Atopic Dermatitis - Drugs.com MedNews
Novartis to receive USD 420 million cash payment from Meda Novartis to focus commercialization efforts on new launch portfolio Basel, April 7, 2011 - Novartis a
View full resource at drugs.com
Tags: Allergies, Eczema, Drug, Novartis, Medical
Most Recently Shared on April 7, 2011 at 12:07 pm By:
Novartis Sells Global Rights to Elidel, A Medicine to Treat Atopic Dermatitis: * Novartis to receive USD 4... http://bit.ly/fZAHZR #drug
Advertisement
